Consensus on infertility treatment related to polycystic ovary syndrome

Fertility and Sterility

Volumn 89, Issue 3, 2008, Pages 505-522

[No Author Info available]

Author keywords

2007 consensus; infertility treatment; Polycystic ovary syndrome

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; AROMATASE INHIBITOR; CLOMIFENE CITRATE; DEXAMETHASONE; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN DERIVATIVE; GONADOTROPIN; INSULIN SENSITIZING AGENT; LETROZOLE; METFORMIN; PIOGLITAZONE; PLACEBO; ROSIGLITAZONE; SIBUTRAMINE; TAMOXIFEN; TETRAHYDROLIPSTATIN;

ADD ON THERAPY; ALCOHOL CONSUMPTION; ALTERNATIVE MEDICINE; ARTICLE; ARTIFICIAL INSEMINATION; BARIATRIC SURGERY; CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CONSENSUS; DIET THERAPY; DRUG DOSE INCREASE; DRUG EFFICACY; EVIDENCE BASED MEDICINE; EXERCISE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HEADACHE; HEALTH HAZARD; HOT FLUSH; HUMAN; INFERTILITY THERAPY; LACTIC ACIDOSIS; LAPAROSCOPIC SURGERY; LIFESTYLE; LIFESTYLE MODIFICATION; LIVE BIRTH; LIVER TOXICITY; LOADING DRUG DOSE; LOW DRUG DOSE; MULTIPLE PREGNANCY; NONHUMAN; OBESITY; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PATIENT COUNSELING; PATIENT MONITORING; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; PREGNANCY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SCREENING; TREATMENT DURATION; TREATMENT INDICATION; VISUAL DISORDER; WEIGHT REDUCTION;

CLOMIPHENE; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; HYPOGLYCEMIC AGENTS; INFERTILITY, FEMALE; LAPAROSCOPY; LIFE STYLE; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY OUTCOME; REPRODUCTIVE TECHNIQUES, ASSISTED; TREATMENT OUTCOME;

EID: 40349085776     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.09.041     Document Type: Article

References (165)

1. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
2. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19 (2004) 41-47
3. Azziz R., Carmina E., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H.F., Futterweit W., et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91 (2006) 4237-4245
4. Franks S. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab 91 (2006) 786-789
5. Pasquali R., Pelusi C., Genghini S., Cacciari M., and Gambineri A. Obesity and reproductive disorders in women. Hum Reprod Update 9 (2003) 359-372
6. Froen J.F., Arnestad M., Frey K., Vege A., Saugstad O.D., and Stray-Pedersen B. Risk factors for sudden intrauterine unexplained death: epidemiologic characteristics of singleton cases in Oslo, Norway, 1986-1995. Am J Obstet Gynecol 184 (2001) 694-702
7. Boomsma C.M., Eijkemans M.J., Hughes E.G., Visser G.H., Fauser B.C., and Macklon N.S. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 12 (2006) 673-683
8. Imani B., Eijkemans M.J., te Velde E.R., Habbema J.D., and Fauser B.C. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 83 (1998) 2361-2365
9. Imani B., Eijkemans M.J., te Velde E.R., Habbema J.D., and Fauser B.C. Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 84 (1999) 1617-1622
10. Mulders A.G., Laven J.S., Eijkemans M.J., Hughes E.G., and Fauser B.C. Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis. Hum Reprod Update 9 (2003) 429-449
11. Balen A.H., Platteau P., Andersen A.N., Devroey P., Sorensen P., Helmgaard L., et al. The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility. BJOG 113 (2006) 1195-1202
12. Gjonnaess H. Ovarian electrocautery in the treatment of women with polycystic ovary syndrome (PCOS). Factors affecting the results. Acta Obstet Gynecol Scand 73 (1994) 407-412
13. Moran L.J., Noakes M., Clifton P.M., Tomlinson L., Galletly C., and Norman R.J. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 88 (2003) 812-819
14. Kiddy D.S., Hamilton-Fairley D., Bush A., Short F., Anyaoku V., Reed M.J., et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 36 (1992) 105-111
15. Yanovski S.Z., and Yanovski J.A. Obesity. N Engl J Med 346 (2002) 591-602
16. Wadden T.A., Berkowitz R.I., Womble L.G., Sarwer D.B., Phelan S., Cato R.K., et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med 353 (2005) 2111-2120
17. Sjostrom L., Lindroos A.K., Peltonen M., Torgerson J., Bouchard C., Carlsson B., et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351 (2004) 2683-2693
18. Morris S.N., Missmer S.A., Cramer D.W., Powers R.D., McShane P.M., and Hornstein M.D. Effects of lifetime exercise on the outcome of in vitro fertilization. Obstet Gynecol 108 (2006) 938-945
19. Tsagareli V., Noakes M., and Norman R.J. Effect of a very-low-calorie diet on in vitro fertilization outcomes. Fertil Steril 86 (2006) 227-229
20. Marsh K., and Brand-Miller J. The optimal diet for women with polycystic ovary syndrome?. Br J Nutr 94 (2005) 154-165
21. Moran L.J., Noakes M., Clifton P.M., Wittert G.A., Tomlinson L., Galletly C., et al. Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition. J Clin Endocrinol Metab 89 (2004) 3337-3344
22. Stamets K., Taylor D.S., Kunselman A., Demers L.M., Pelkman C.L., and Legro R.S. A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome. Fertil Steril 81 (2004) 630-637
23. Reaven G.M. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu Rev Nutr 25 (2005) 391-406
24. Wright C.E., Zborowski J.V., Talbott E.O., Hugh-Pemu K., and Youk A. Dietary intake, physical activity, and obesity in women with polycystic ovary syndrome. Int J Obes Relat Metab Disord 28 (2004) 1026-1032
25. Rich-Edwards J.W., Spiegelman D., Garland M., Hertzmark E., Hunter D.J., Colditz G.A., et al. Physical activity, body mass index, and ovulatory disorder infertility. Epidemiology 13 (2002) 184-190
26. Bruner B., Chad K., and Chizen D. Effects of exercise and nutritional counseling in women with polycystic ovary syndrome. Appl Physiol Nutr Metab 31 (2006) 384-391
27. Crosignani P.G., Colombo M., Vegetti W., Somigliana E., Gessati A., and Ragni G. Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod 18 (2003) 1928-1932
28. Moran L.J., Brinkworth G., Noakes M., and Norman R.J. Effects of lifestyle modification in polycystic ovarian syndrome. Reprod Biomed Online 12 (2006) 569-578
29. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002) 393-403
30. Alvarez-Blasco F., Botella-Carretero J.I., San Millan J.L., and Escobar-Morreale H.F. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch Intern Med 166 (2006) 2081-2086
31. Escobar-Morreale H.F., Botella-Carretero J.I., Alvarez-Blasco F., Sancho J., and San Millán J.L. The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 90 (2005) 6364-6369
32. Sabuncu T., Harma M., Harma M., Nazligul Y., and Kilic F. Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome. Fertil Steril 80 (2003) 1199-1204
33. Jayagopal V., Kilpatrick E.S., Holding S., Jennings P.E., and Atkin S.L. Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome. J Clin Endocrinol Metab 90 (2005) 729-733
34. Pi-Sunyer F.X., Aronne L.J., Heshmati H.M., Devin J., and Rosenstock J. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 295 (2006) 761-775
35. Imani B., Eijkemans M.J., te Velde E.R., Habbema J.D., and Fauser B.C. A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertil Steril 77 (2002) 91-97
36. Eijkemans M.J., Imani B., Mulders A.G., Habbema J.D., and Fauser B.C. High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum Reprod 18 (2003) 2357-2362
37. Dickey R.P., Taylor S.N., Curole D.N., Rye P.H., and Pyrzak R. Incidence of spontaneous abortion in clomiphene pregnancies. Hum Reprod 11 (1996) 2623-2628
38. Legro R.S., Barnhart H.X., Schlaff W.D., Carr B.R., Diamond M.P., Carson S.A., et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 356 (2007) 551-566
39. Kosmas I.P., Tatsioni A., Fatemi H.M., Kolibianakis E.M., Tournaye H., and Devroey P. Human chorionic gonadotropin administration vs. luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene citrate: a meta-analysis. Fertil Steril 87 (2007) 607-612
40. Homburg R. Clomiphene citrate-end of an era? A mini-review. Hum Reprod 20 (2005) 2043-2051
41. Messinis I.E. Ovulation induction: a mini review. Hum Reprod 20 (2005) 2688-2697
42. Hammond M.G., Halme J.K., and Talbert L.M. Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation. Obstet Gynecol 62 (1983) 196-202
43. Kousta E., White D.M., and Franks S. Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update 3 (1997) 359-365
44. Messinis I.E., and Milingos S.D. Current and future status of ovulation induction in polycystic ovary syndrome. Hum Reprod Update 3 (1997) 235-253
45. Kolibianakis E.M., Zikopoulos K.A., Fatemi H.M., Osmanagaoglu K., Evenpoel J., Van S.A., et al. Endometrial thickness cannot predict ongoing pregnancy achievement in cycles stimulated with clomiphene citrate for intrauterine insemination. Reprod Biomed Online 8 (2004) 115-118
46. Moll E., Bossuyt P.M., Korevaar J.C., Lambalk C.B., and van der Veen F. Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. BMJ 332 (2006) 1485
47. Daly D.C., Walters C.A., Soto-Albors C.E., Tohan N., and Riddick D.H. A randomized study of dexamethasone in ovulation induction with clomiphene citrate. Fertil Steril 41 (1984) 844-848
48. Messinis I.E., and Nillius S.J. Comparison between tamoxifen and clomiphene for induction of ovulation. Acta Obstet Gynecol Scand 61 (1982) 377-379
49. Steiner A.Z., Terplan M., and Paulson R.J. Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis. Hum Reprod 20 (2005) 1511-1515
50. Alivanis P., Giannikouris I., Paliuras C., Arvanitis A., Volanaki M., and Zervos A. Metformin-associated lactic acidosis treated with continuous renal replacement therapy. Clin Ther 28 (2006) 396-400
51. Nissen S.E., and Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356 (2007) 2457-2471
52. Lord J.M., Flight I.H., and Norman R.J. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst Rev 3 (2003) CD003053
53. Tang T., Glanville J., Hayden C.J., White D., Barth J.H., and Balen A.H. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Hum Reprod 21 (2006) 80-89
54. Harborne L., Fleming R., Lyall H., Norman J., and Sattar N. Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. Lancet 361 (2003) 1894-1901
55. Baillargeon J.P., Jakubowicz D.J., Iuorno M.J., Jakubowicz S., and Nestler J.E. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity. Fertil Steril 82 (2004) 893-902
56. Legro R.S., Zaino R.J., Demers L.M., Kunselman A.R., Gnatuk C.L., Williams N.I., et al. The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome. Am J Obstet Gynecol 196 (2007) 402-410
57. Vanky E., Salvesen K.A., Heimstad R., Fougner K.J., Romundstad P., and Carlsen S.M. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod 19 (2004) 1734-1740
58. Vanky E., Hjorth-Hansen H., and Carlsen S.M. Metformin and early pregnancy?. Fertil Steril 86 (2006) 1551-1552
59. Brown J.B. Pituitary control of ovarian function-concepts derived from gonadotrophin therapy. Aust NZ J Obstet Gynaecol 18 (1978) 46-54
60. Baird D.T. A model for follicular selection and ovulation: lessons from superovulation. J Steroid Biochem 27 (1987) 15-23
61. Dor J., Itzkowic D.J., Mashiach S., Lunenfeld B., and Serr D.M. Cumulative conception rates following gonadotropin therapy. Am J Obstet Gynecol 136 (1980) 102-105
62. Thompson C.R., and Hansen L.M. Pergonal (menotropins): a summary of clinical experience in the induction of ovulation and pregnancy. Fertil Steril 21 (1970) 844-853
63. Wang C.F., and Gemzell C. The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease. Fertil Steril 33 (1980) 479-486
64. Balasch J., Fabregues F., Creus M., Casamitjana R., Puerto B., and Vanrell J.A. Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: a prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol. J Assist Reprod Genet 17 (2000) 561-565
65. Calaf Alsina J., Ruiz Balda J.A., Romeu Sarrio A., Caballero Fernandez V., Cano Trigo I., Gomez Parga J.L., et al. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial. BJOG 110 (2003) 1072-1077
66. Hayden C.J., Rutherford A.J., and Balen A.H. Induction of ovulation with the use of a starting dose of 50 units of recombinant human follicle-stimulating hormone (Puregon). Fertil Steril 71 (1999) 106-108
67. White D.M., Polson D.W., Kiddy D., Sagle P., Watson H., Gilling-Smith C., et al. Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J Clin Endocrinol Metab 81 (1996) 3821-3824
68. Brzyski R.G., Grow D.R., Sims J.A., and Seltman H.J. Increase in androgen:estrogen ratio specifically during low-dose follicle-stimulating hormone therapy for polycystic ovary syndrome. Fertil Steril 64 (1995) 693-697
69. Buvat J., Buvat-Herbaut M., Marcolin G., Dehaene J.L., Verbecq P., and Renouard O. Purified follicle-stimulating hormone in polycystic ovary syndrome: slow administration is safer and more effective. Fertil Steril 52 (1989) 553-559
70. Dale O., Tanbo T., Lunde O., and Abyholm T. Ovulation induction with low-dose follicle-stimulating hormone in women with the polycystic ovary syndrome. Acta Obstet Gynecol Scand 72 (1993) 43-46
71. Polson D.W., Mason H.D., Saldahna M.B., and Franks S. Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 26 (1987) 205-212
72. Sagle M.A., Hamilton-Fairley D., Kiddy D.S., and Franks S. A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome. Fertil Steril 55 (1991) 56-60
73. Seibel M.M., Kamrava M.M., McArdle C., and Taymor M.L. Treatment of polycystic ovary disease with chronic low-dose follicle stimulating hormone: biochemical changes and ultrasound correlation. Int J Fertil 29 (1984) 39-43
74. Schoot D.C., Pache T.D., Hop W.C., de Jong F.H., and Fauser B.C. Growth patterns of ovarian follicles during induction of ovulation with decreasing doses of human menopausal gonadotropin following presumed selection in polycystic ovary syndrome. Fertil Steril 57 (1992) 1117-1120
75. van Dessel H.J., Schoot B.C., Schipper I., Dahl K.D., and Fauser B.C. Circulating immunoreactive and bioactive follicle stimulating hormone concentrations in anovulatory infertile women and during gonadotrophin induction of ovulation using a decremental dose regimen. Hum Reprod 11 (1996) 478-485
76. Fauser B.C., and Van Heusden A.M. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev 18 (1997) 71-106
77. Balasch J., Fabregues F., Creus M., Puerto B., Penarrubia J., and Vanrell J.A. Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens. Hum Reprod 16 (2001) 652-656
78. van Santbrink E.J., and Fauser B.C. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens. J Clin Endocrinol Metab 82 (1997) 3597-3602
79. Christin-Maitre S., and Hugues J.N. A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome. Hum Reprod 18 (2003) 1626-1631
80. van Santbrink E.J., Donderwinkel P.F., van Dessel T.J., and Fauser B.C. Gonadotrophin induction of ovulation using a step-down dose regimen: single-centre clinical experience in 82 patients. Hum Reprod 10 (1995) 1048-1053
81. Hugues J.N., Cedrin-Durnerin I., Avril C., Bulwa S., Herve F., and Uzan M. Sequential step-up and step-down dose regimen: an alternative method for ovulation induction with follicle-stimulating hormone in polycystic ovarian syndrome. Hum Reprod 11 (1996) 2581-2584
82. Hugues J.N., Cedrin-Durnerin I., Howles C.M., Amram M., Angelini A., Balen A., et al. The use of a decremental dose regimen in patients treated with a chronic low-dose step-up protocol for WHO Group II anovulation: a prospective randomized multicentre study. Hum Reprod 21 (2006) 2817-2822
83. Jacobs H.S., and Homburg R.R. The endocrinology of conception. Baillieres Clin Endocrinol Metab 4 (1990) 195-205
84. Willis D., Mason H., Gilling-Smith C., and Franks S. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 81 (1996) 302-309
85. Willis D.S., Watson H., Mason H.D., Galea R., Brincat M., and Franks S. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J Clin Endocrinol Metab 83 (1998) 3984-3991
86. Balen A.H., Tan S.L., and Jacobs H.S. Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage. Br J Obstet Gynaecol 100 (1993) 1082-1089
87. Homburg R., Armar N.A., Eshel A., Adams J., and Jacobs H.S. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ 297 (1988) 1024-1026
88. Regan L., Owen E.J., and Jacobs H.S. Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet 336 (1990) 1141-1144
89. Tarlatzis B.C., Grimbizis G., Pournaropoulos F., Bontis J., Lagos S., Spanos E., et al. The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques. Hum Reprod 10 (1995) 2545-2549
90. Rai R., Backos M., Rushworth F., and Regan L. Polycystic ovaries and recurrent miscarriage-a reappraisal. Hum Reprod 15 (2000) 612-615
91. Oliveira J.B., Mauri A.L., Petersen C.G., Martins A.M., Cornicelli J., Cavanha M., et al. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulation hormone during induced ovarian stimulation in the GnRH-agonist protocol: a meta-analysis. J Assist Reprod Genet 24 (2007) 67-75
92. Dodson W.C., Hughes C.L., Whitesides D.B., and Haney A.F. The effect of leuprolide acetate on ovulation induction with human menopausal gonadotropins in polycystic ovary syndrome. J Clin Endocrinol Metab 65 (1987) 95-100
93. Fleming R., Haxton M.J., Hamilton M.P., McCune G.S., Black W.P., MacNaughton M.C., et al. Successful treatment of infertile women with oligomenorrhoea using a combination of an LHRH agonist and exogenous gonadotrophins. Br J Obstet Gynaecol 92 (1985) 369-373
94. Fleming R., Haxton M.J., Hamilton M.P., Conaghan C.J., Black W.P., Yates R.W., et al. Combined gonadotropin-releasing hormone analog and exogenous gonadotropins for ovulation induction in infertile women: efficacy related to ovarian function assessment. Am J Obstet Gynecol 159 (1988) 376-381
95. Buckler H.M., Critchley H.O., Cantrill J.A., Shalet S.M., Anderson D.C., and Robertson W.R. Efficacy of low dose purified FSH in ovulation induction following pituitary desensitization in polycystic ovarian syndrome. Clin Endocrinol (Oxf) 38 (1993) 209-217
96. Charbonnel B., Krempf M., Blanchard P., Dano F., and Delage C. Induction of ovulation in polycystic ovary syndrome with a combination of a luteinizing hormone-releasing hormone analog and exogenous gonadotropins. Fertil Steril 47 (1987) 920-924
97. Homburg R., Eshel A., Kilborn J., Adams J., and Jacobs H.S. Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries. Hum Reprod 5 (1990) 32-35
98. Scheele F., Hompes P.G., van der M.M., Schoute E., and Schoemaker J. The effects of a gonadotrophin-releasing hormone agonist on treatment with low dose follicle stimulating hormone in polycystic ovary syndrome. Hum Reprod 8 (1993) 699-704
99. van der Meer M., Hompes P.G., Scheele F., Schoute E., Popp-Snijders C., and Schoemaker J. The importance of endogenous feedback for monofollicular growth in low-dose step-up ovulation induction with follicle-stimulating hormone in polycystic ovary syndrome: a randomized study. Fertil Steril 66 (1996) 571-576
100. Bachus K.E., Hughes Jr. C.L., Haney A.F., and Dodson W.C. The luteal phase in polycystic ovary syndrome during ovulation induction with human menopausal gonadotropin with and without leuprolide acetate. Fertil Steril 54 (1990) 27-31
101. Clifford K., Rai R., Watson H., Franks S., and Regan L. Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial. BMJ 312 (1996) 1508-1511
102. Homburg R., Levy T., Berkovitz D., Farchi J., Feldberg D., Ashkenazi J., et al. Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome. Fertil Steril 59 (1993) 527-531
103. Homburg R., and Howles C.M. Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements. Hum Reprod Update 5 (1999) 493-499
104. Kamrava M.M., Seibel M.M., Berger M.J., Thompson I., and Taymor M.L. Reversal of persistent anovulation in polycystic ovarian disease by administration of chronic low-dose follicle-stimulating hormone. Fertil Steril 37 (1982) 520-523
105. Farhi J., West C., Patel A., and Jacobs H.S. Treatment of anovulatory infertility: the problem of multiple pregnancy. Hum Reprod 11 (1996) 429-434
106. Dickey R.P., Taylor S.N., Lu P.Y., Sartor B.M., Rye P.H., and Pyrzak R. Risk factors for high-order multiple pregnancy and multiple birth after controlled ovarian hyperstimulation: results of 4,062 intrauterine insemination cycles. Fertil Steril 83 (2005) 671-683
107. Tur R., Barri P.N., Coroleu B., Buxaderas R., Martinez F., and Balasch J. Risk factors for high-order multiple implantation after ovarian stimulation with gonadotrophins: evidence from a large series of 1878 consecutive pregnancies in a single centre. Hum Reprod 16 (2001) 2124-2129
108. Leader A. Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low-dose step-up protocol with weekly increments of 25 international units of follicle-stimulating hormone. Fertil Steril 85 (2006) 1766-1773
109. Practice Committee of the American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril 86 Suppl (2006) S178-S183
110. Balasch J., Tur R., Alvarez P., Bajo J.M., Bosch E., Bruna I., et al. The safety and effectiveness of stepwise and low-dose administration of follicle stimulating hormone in WHO group II anovulatory infertile women: evidence from a large multicenter study in Spain. J Assist Reprod Genet 13 (1996) 551-556
111. Hamilton-Fairley D., Kiddy D., Watson H., Sagle M., and Franks S. Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome. Hum Reprod 6 (1991) 1095-1099
112. Hamilton-Fairley D., and Franks S. Common problems in induction of ovulation. Baillieres Clin Obstet Gynaecol 4 (1990) 609-625
113. Fauser B.C., and Macklon N.S. Medical approaches to ovarian stimulation for infertility. In: Strauss J.F., and Barbieri R.L. (Eds). Yen and Jaffe's reproductive endocrinology (2004), Elsevier Saunders, Philadelphia 965-1012
114. Gjonnaess H. Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope. Fertil Steril 41 (1984) 20-25
115. Rimington M.R., Walker S.M., and Shaw R.W. The use of laparoscopic ovarian electrocautery in preventing cancellation of in-vitro fertilization treatment cycles due to risk of ovarian hyperstimulation syndrome in women with polycystic ovaries. Hum Reprod 12 (1997) 1443-1447
116. Balen A. Surgical management of PCOS. Best Pract Res Clin Endocrinol Metab 20 (2006) 271-280
117. Farquhar C., Lilford R.J., Marjoribanks J., and Vandekerckhove P. Laparoscopic "drilling" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev 3 (2007) CD001122
118. Fernandez H., Alby J.D., Gervaise A., de Tayrac R., and Frydman R. Operative transvaginal hydrolaparoscopy for treatment of polycystic ovary syndrome: a new minimally invasive surgery. Fertil Steril 75 (2001) 607-611
119. Naether O.G., Baukloh V., Fischer R., and Kowalczyk T. Long-term follow-up in 206 infertility patients with polycystic ovarian syndrome after laparoscopic electrocautery of the ovarian surface. Hum Reprod 9 (1994) 2342-2349
120. Amer S.A., Li T.C., and Cooke I.D. Laparoscopic ovarian diathermy in women with polycystic ovarian syndrome: a retrospective study on the influence of the amount of energy used on the outcome. Hum Reprod 17 (2002) 1046-1051
121. Amer S.A., Li T.C., and Cooke I.D. A prospective dose-finding study of the amount of thermal energy required for laparoscopic ovarian diathermy. Hum Reprod 18 (2003) 1693-1698
122. Malkawi H.Y., Qublan H.S., and Hamaideh A.H. Medical vs. surgical treatment for clomiphene citrate-resistant women with polycystic ovary syndrome. J Obstet Gynaecol 23 (2003) 289-293
123. Bayram N., van Wely M., Kaaijk E.M., Bossuyt P.M., and van der Veen F. Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial. BMJ 328 (2004) 192
124. Lazovic G., Milacic D., Terzic M., Spremovic S., and Mitijasevic S. Medicaments or surgical therapy of PCOS. Fertil Steril 70 Suppl (1998) S472
125. Farquhar C.M., Williamson K., Gudex G., Johnson N.P., Garland J., and Sadler L. A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate-resistant polycystic ovary syndrome. Fertil Steril 78 (2002) 404-411
126. Kaya H., Sezik M., and Ozkaya O. Evaluation of a new surgical approach for the treatment of clomiphene citrate-resistant infertility in polycystic ovary syndrome: laparoscopic ovarian multi-needle intervention. J Minim Invasive Gynecol 12 (2005) 355-358
127. Vegetti W., Ragni G., Baroni E., Testa G., Marsico S., Riccaboni A., et al. Laparoscopic ovarian versus low-dose pure FSH in anovulatory clomiphene-resistant patients with polycystic ovarian syndrome: randomized prospective study. [abstract]. Hum Reprod 13 (1998) 120
128. Farquhar C.M., Williamson K., Brown P.M., and Garland J. An economic evaluation of laparoscopic ovarian diathermy versus gonadotrophin therapy for women with clomiphene citrate resistant polycystic ovary syndrome. Hum Reprod 19 (2004) 1110-1115
129. van Wely M., Bayram N., van der Veen F., and Bossuyt P.M. An economic comparison of a laparoscopic electrocautery strategy and ovulation induction with recombinant FSH in women with clomiphene citrate-resistant polycystic ovary syndrome. Hum Reprod 19 (2004) 1741-1745
130. Abdel G.A., Khatim M.S., Alnaser H.M., Mowafi R.S., and Shaw R.W. Ovarian electrocautery: responders versus non-responders. Gynecol Endocrinol 7 (1993) 43-48
131. Li T.C., Saravelos H., Chow M.S., Chisabingo R., and Cooke I.D. Factors affecting the outcome of laparoscopic ovarian drilling for polycystic ovarian syndrome in women with anovulatory infertility. Br J Obstet Gynaecol 105 (1998) 338-344
132. Cohen J., and Audebert A. De la "mecanique" au fonctionnel: place des traitements chirurgicaux in endoscopiques dans les dystrophies ovariennes. Dystrophies ovairennes (1989), Masson, Paris 183-192
133. Gurgan T., Urman B., Aksu T., Yarali H., Develioglu O., and Kisnisci H.A. The effect of short-interval laparoscopic lysis of adhesions on pregnancy rates following Nd-YAG laser photocoagulation of polycystic ovaries. Obstet Gynecol 80 (1992) 45-47
134. Greenblatt E.M., and Casper R.F. Adhesion formation after laparoscopic ovarian cautery for polycystic ovarian syndrome: lack of correlation with pregnancy rate. Fertil Steril 60 (1993) 766-770
135. Amer S.A., Banu Z., Li T.C., and Cooke I.D. Long-term follow-up of patients with polycystic ovary syndrome after laparoscopic ovarian drilling: endocrine and ultrasonographic outcomes. Hum Reprod 17 (2002) 2851-2857
136. Kaaijk E.M., Hamerlynck J.V., Beek J.F., and van der Veen F. Clinical outcome after unilateral oophorectomy in patients with polycystic ovary syndrome. Hum Reprod 14 (1999) 889-892
137. van Santbrink E.J., and Fauser B.C. Is there a future for ovulation induction in the current era of assisted reproduction?. Hum Reprod 18 (2003) 2499-2502
138. Eijkemans M.J., Polinder S., Mulders A.G., Laven J.S., Habbema J.D., and Fauser B.C. Individualized cost-effective conventional ovulation induction treatment in normogonadotrophic anovulatory infertility (WHO group 2). Hum Reprod 20 (2005) 2830-2837
139. Heijnen E.M., Eijkemans M.J., De Klerk C., Polinder S., Beckers N.G., Klinkert E.R., et al. A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet 369 (2007) 743-749
140. Papanikolaou E.G., Camus M., Kolibianakis E.M., Van Landuyt L., Van Steirteghem A., and Devroey P. In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos. N Engl J Med 354 (2006) 1139-1146
141. Dor J., Shulman A., Levran D., Ben-Rafael Z., Rudak E., and Mashiach S. The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility. Hum Reprod 5 (1990) 816-818
142. Urman B., Fluker M.R., Yuen B.H., Fleige-Zahradka B.G., Zouves C.G., and Moon Y.S. The outcome of in vitro fertilization and embryo transfer in women with polycystic ovary syndrome failing to conceive after ovulation induction with exogenous gonadotropins. Fertil Steril 57 (1992) 1269-1273
143. Griesinger G., Diedrich K., Tarlatzis B.C., and Kolibianakis E.M. GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis. Reprod Biomed Online 13 (2006) 628-638
144. Heijnen E.M., Eijkemans M.J., Hughes E.G., Laven J.S., Macklon N.S., and Fauser B.C. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update 12 (2006) 13-21
145. Tang T., Glanville J., Orsi N., Barth J.H., and Balen A.H. The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod 21 (2006) 1416-1425
146. Cohlen B.J., Vandekerckhove P., te Velde E.R., and Habbema J.D. Timed intercourse versus intra-uterine insemination with or without ovarian hyperstimulation for subfertility in men. Cochrane Database Syst Rev 2 (2000) CD000360
147. ESHRE Capri Workshop Group. Mono-ovulatory cycles: a key goal in profertility programmes. Hum Reprod Update 9 (2003) 263-274
148. De Geyter C., De Geyter M., Castro E., Bals-Pratsch M., Nieschlag E., and Schneider H.P. Experience with transvaginal ultrasound-guided aspiration of supernumerary follicles for the prevention of multiple pregnancies after ovulation induction and intrauterine insemination. Fertil Steril 65 (1996) 1163-1168
149. Cantineau A.E., Heineman M.J., and Cohlen B.J. Single versus double intrauterine insemination (IUI) in stimulated cycles for subfertile couples. Cochrane Database Syst Rev 1 (2003) CD003854
150. Gerli S., Casini M.L., Unfer V., Costabile L., Bini V., and Di Renzo G.C. Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles: a prospective, randomized analysis of cost effectiveness. Fertil Steril 82 (2004) 573-578
151. Mitwally M.F., and Casper R.F. Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation. J Soc Gynecol Investig 11 (2004) 406-415
152. Palomba S., Falbo A., Orio Jr. F., Manguso F., Russo T., Tolino A., et al. A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination. Hum Reprod 20 (2005) 2879-2886
153. van Santbrink E.J., Eijkemans M.J., Laven J.S., and Fauser B.C. Patient-tailored conventional ovulation induction algorithms in anovulatory infertility. Trends Endocrinol Metab 16 (2005) 381-389
154. Hamilton-Fairley D., Kiddy D., Watson H., Paterson C., and Franks S. Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin. Br J Obstet Gynecol 99 (1992) 128-131
155. Strowitzki T., Seehaus D., Korell M., and Hepp H. Low-dose FSH stimulation in polycystic ovary syndrome: comparison of 3 FSH preparations. Exp Clin Endocrinol Diabetes 106 (1998) 435-439
156. Vicino M., Loverro G., Bettocchi S., Simonetti S., Mei L., and Selvaggi L. Predictive value of serum androstenedione basal levels on the choice of gonadotropin or laparoscopic ovarian electrocautery as ovulation induction in clomiphene citrate-resistant patients with polycystic ovary syndrome. Gynecol Endocrinol 14 (2000) 42-49
157. Yarali H., Bukulmez O., and Gurgan T. Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective randomized study. Fertil Steril 72 (1999) 276-281
158. Urman B., Sarac E., Dogan L., and Gurgan T. Pregnancy in infertile PCOD patients. Complications and outcome. J Reprod Med 42 (1997) 501-505
159. Fridstrom M., Nisell H., Sjoblom P., and Hillensjo T. Are women with polycystic ovary syndrome at an increased risk of pregnancy-induced hypertension and/or preeclampsia?. Hypertens Pregnancy 18 (1999) 73-80
160. Mikola M., Hiilesmaa V., Halttunen M., Suhonen L., and Tiitinen A. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod 16 (2001) 226-229
161. Weerakiet S., Srisombut C., Rojanasakul A., Panburana P., Thakkinstian A., and Herabutya Y. Prevalence of gestational diabetes mellitus and pregnancy outcomes in Asian women with polycystic ovary syndrome. Gynecol Endocrinol 19 (2004) 134-140
162. Sir-Petermann T., Hitchsfeld C., Maliqueo M., Codner E., Echiburu B., Gazitua R., Recabarren S., and Cassorla F. Birth weight in offspring of mothers with polycystic ovarian syndrome. Hum Reprod 20 (2005) 2122-2126
163. Hoeger K.M., Kochman L., Wixom N., Craig K., Miller R.K., and Guzick D.S. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study. Fertil Steril 82 (2004) 421-429
164. Hull M.G. Gonadotropin therapy in anovulatory infertility. In: Howies C.M. (Ed). Gonadotrophins, GnRH analogues, and growth factors in infertility: future perspectives (1991), Alden Press, Oxford 56-61
165. Balen A.H., Braat D.D., West C., Patel A., and Jacobs H.S. Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients. Hum Reprod 9 (1994) 1563-1570